Skip to content

A Randomized Controlled Trial for Compound Diandao Pulvis Paste for External Use in the Treatment of Acne

A Randomized Controlled Trial for Compound Diandao Pulvis Paste for External Use in the Treatment of Acne

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020404
Enrollment
Unknown
Registered
2018-12-28
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne

Interventions

Experimental group A:External application of Compound Diandao Pulvis Paste.
Control group B:External application of Adapalene Gel (Duff) on the skin lesion.

Sponsors

Integrated Traditional Chinese and Western Medicine Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Patient who is diagnosed with acne vulgaris, according to the diagnosis of this disease. The degree of disease was graded in I-III. 2. Aged 14-40 years old male and female; 3. Willing to sign informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients who do not meet the inclusion criteria; 2. Occupational acne caused by chemicals; Drug-induced acne; Severe acne such as acne conglobata and acne necrotica; 3. Women in pregnancy and lactation; 4. patients with serious primary diseases such as heart, liver, kidney and hematopoietic system and mental disease; 5. patients with active herpes simplex, vitiligo and psoriasis on the face; 6. Oral medication for acne was used within 1 month before treatment and external medication for acne was used within 1 week before treatment; 7. Acne with cysts.

Design outcomes

Primary

MeasureTime frame
GAGS score;

Secondary

MeasureTime frame
erythema score;skin irritation response score;VAS score;skin oil content;

Countries

China

Contacts

Public ContactYang Liu

Integrated Traditional Chinese and Western Medicine Hospital of Southern Medical University

yangliusmu@163.com+86 020-61650137

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026